UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reproductive healthcare utilization in patients with bleeding disorders

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1741-1743

2023

Volltextzugriff (PDF)

RNAing toward a new therapy for hemophilia

Blood, 2024-05, Vol.143 (22), p.2219-2221

2024

Volltextzugriff (PDF)

“A New Hemophilia Carrier Nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH”: Reply to comment

Journal of thrombosis and haemostasis, 2022-07, Vol.20 (7), p.1745-1746

Sidonio, Robert F.

2022

Volltextzugriff (PDF)

Unresolved hemostasis issues in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-04, Vol.30 (S3), p.70-77

2024

Volltextzugriff (PDF)

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?

Expert opinion on pharmacotherapy, 2024-07, Vol.25 (11), p.1427-1438

2024

Volltextzugriff (PDF)

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

British journal of haematology, 2015-07, Vol.170 (2), p.223-228

2015

Volltextzugriff (PDF)

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.789-796

2019

Volltextzugriff (PDF)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1883-1887

2021

Volltextzugriff (PDF)

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-05, Vol.28 (S4), p.18-25

2022

Volltextzugriff (PDF)

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.404-407

2023

Volltextzugriff (PDF)

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Blood reviews, 2021-05, Vol.47, p.100759-100759, Article 100759

2021

Volltextzugriff (PDF)

Hemophilia B (Factor IX Deficiency)

Hematology/oncology clinics of North America, 2021-12, Vol.35 (6), p.1143-1155

2021

Volltextzugriff (PDF)

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Pediatric blood & cancer, 2024-01, Vol.71 (1), p.e30727-n/a

2024

Volltextzugriff (PDF)

Diagnostic pitfalls and conundrums in type 1 von Willebrand disease

Hematology, 2022-12, Vol.2022 (1), p.618-623

2022

Volltextzugriff (PDF)

Substitution therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-02, Vol.27 (S3), p.53-59

2021

Volltextzugriff (PDF)

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

American journal of hematology, 2023-10, Vol.98 (10), p.E285-E287

2023

Volltextzugriff (PDF)

Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data

Expert review of hematology, 2024-06, Vol.17 (6), p.261-268

2024

Volltextzugriff (PDF)

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Pediatric blood & cancer, 2024-06, Vol.71 (6), p.e30944-n/a

2024

Volltextzugriff (PDF)

Plasma factor IX: The tip of the iceberg?

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.329-331

2021

Volltextzugriff (PDF)

Thrombin generation and implications for hemophilia therapies: A narrative review

Research and practice in thrombosis and haemostasis, 2023-01, Vol.7 (1), p.100018-100018, Article 100018

2023

Volltextzugriff (PDF)

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.905-913

2024

Volltextzugriff (PDF)

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

Expert review of hematology, 2023-03, Vol.16 (sup1), p.39-54

2023

Volltextzugriff (PDF)

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.e128-e129

2020

Volltextzugriff (PDF)

Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-01, Vol.28 (1), p.73-79

2022

Volltextzugriff (PDF)

Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study

Orphanet journal of rare diseases, 2021-04, Vol.16 (1), p.189-189, Article 189

2021

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(177)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Reproductive healthcare utilization in patients with bleeding disorders

RNAing toward a new therapy for hemophilia

“A New Hemophilia Carrier Nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH”: Reply to comment

Unresolved hemostasis issues in haemophilia

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Hemophilia B (Factor IX Deficiency)

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Diagnostic pitfalls and conundrums in type 1 von Willebrand disease

Substitution therapy

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Plasma factor IX: The tip of the iceberg?

Thrombin generation and implications for hemophilia therapies: A narrative review

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study

Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study

Aktive Filter

Suchergebnisse filtern